Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling PathwaysDisease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC)Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers
P921
description
chemotherapy regimen
@en
фолфири
@ru
name
FOLFIRI
@de
FOLFIRI
@en
FOLFIRI
@es
FOLFIRI
@fr
FOLFIRI
@it
FOLFIRI
@ja
FOLFIRI
@nl
FOLFIRI
@ru
type
label
FOLFIRI
@de
FOLFIRI
@en
FOLFIRI
@es
FOLFIRI
@fr
FOLFIRI
@it
FOLFIRI
@ja
FOLFIRI
@nl
FOLFIRI
@ru
prefLabel
FOLFIRI
@de
FOLFIRI
@en
FOLFIRI
@es
FOLFIRI
@fr
FOLFIRI
@it
FOLFIRI
@ja
FOLFIRI
@nl
FOLFIRI
@ru
P527
P6366
P646
P6366
2776705615